Head of US Operations
Emmanuel Coeytaux is an experienced biotech executive with nearly 20 years of experience in developing and bringing new therapies to patients and physicians. He has worked with Steba Biotech since 2015, initially focusing on the European approval of Steba’s platform and the company corporate development. His main focus is now on the FDA submission and launch preparation of Steba’s platform in the US, along with the development of oncology indications beyond prostate cancer. Prior to Steba Biotech, he was VP Value & Access Strategy at Analytica Laser (acquired by Certara). Previously, he led the R&D Strategy group of Sanofi Genzyme and was a Principal at the Boston Consulting Group. He holds a master’s degree in science from Ecole Polytechnique in France and received his PhD in Microbiology and Virology from the Paris Diderot University.